Alvotech Ordinary Shares (ALVO)
Alvotech is a global biopharmaceutical company specializing in the development and manufacturing of high-quality biosimilar medicines. Focused on creating affordable alternatives to existing biologic treatments, Alvotech aims to enhance patient access to vital therapies across various therapeutic areas.
Company News
Alvotech announced leadership changes in its global business development team, with Anil Okay stepping down, and new appointments of Trisha Durant, Harshika Sarbajna, and Agne Pasko in key commercial roles.
Alvotech acquired Ivers-Lee Group, a Swiss pharmaceutical packaging specialist, to boost its biosimilar production capabilities and prepare for three product launches in 2025.
Here is how Alvotech (ALVO) and Atossa Genetics Inc. (ATOS) have performed compared to their sector so far this year.
The biosimilar drug company's shares rebounded a day after it announced that the FDA had dealt it setback.